Richard Marsden
Chief Executive Officer bei SYNAIRGEN PLC
Vermögen: 77 302 $ am 30.04.2024
Aktive Positionen von Richard Marsden
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SYNAIRGEN PLC | Director/Board Member | 01.06.2004 | - |
| Chief Executive Officer | 01.06.2004 | - | |
Synairgen Research Ltd.
 Synairgen Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Synairgen Plc, Synairgen Research Ltd. is a British company that engages in respiratory biology and develops novel therapies. The private company is based in Southampton, UK. Synairgen Research was founded in 2003. | Director/Board Member | 07.06.2004 | - |
Karriereverlauf von Richard Marsden
Ehemalige bekannte Positionen von Richard Marsden
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Southampton Asset Management Ltd.
 Southampton Asset Management Ltd. Investment ManagersFinance Southampton Asset Management Ltd (SAM) is a venture capital firm, a subsidiary of University of Southampton Holdings Ltd. The firm is headquartered in Southampton, United Kingdom. | Director/Board Member | 04.12.2013 | 17.03.2014 |
Respironics Ltd.
 Respironics Ltd. Financial ConglomeratesFinance Respironics Ltd. develops and manufactures medical and healthcare products. Its products include Porta-Neb, Freeway Freedom, Sidestream, and Ventstream. The company was founded in 1977 and is headquartered in Bognor Regis, the United Kingdom. | Corporate Officer/Principal | 01.01.2003 | 01.01.2003 |
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - | - |
Statistik
International
| Vereinigtes Königreich | 6 |
Operativ
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 3 |
| Finance | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SYNAIRGEN PLC | Health Technology |
| Private Unternehmen | 4 |
|---|---|
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Respironics Ltd.
Respironics Ltd. Financial ConglomeratesFinance Respironics Ltd. develops and manufactures medical and healthcare products. Its products include Porta-Neb, Freeway Freedom, Sidestream, and Ventstream. The company was founded in 1977 and is headquartered in Bognor Regis, the United Kingdom. | Finance |
Southampton Asset Management Ltd.
Southampton Asset Management Ltd. Investment ManagersFinance Southampton Asset Management Ltd (SAM) is a venture capital firm, a subsidiary of University of Southampton Holdings Ltd. The firm is headquartered in Southampton, United Kingdom. | Finance |
Synairgen Research Ltd.
Synairgen Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Synairgen Plc, Synairgen Research Ltd. is a British company that engages in respiratory biology and develops novel therapies. The private company is based in Southampton, UK. Synairgen Research was founded in 2003. | Commercial Services |
- Börse
- Insiders
- Richard Marsden
- Erfahrung
